Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
MBBS, MRCP UK ( Internal Medicine), SCE UK (Endocrinology and Diabetes)
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Internal Medicine Specialist
B.Sc, M.B.B.S, M.D Internal Medicine, Certification in Medical Teaching
Diabetologist
M.B.B.S, Dip. In Diabetes
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Gastroenterologist
MBBS, Member of Royal College of Physicians (MRCP), (FCPS) Gastroenterology
Gastroenterologist
MBBS, Member of Royal College of Physicians (MRCP), (FCPS) Gastroenterology
Nephrologist
MBBS, FCPS (Nephrology)
Endocrinologist
MBBS, MCPS (Medicine), FCPS ( Medicine), FCPS (Endocrinology), SCE (Endocrinology & Diabetes, UK)
Endocrinologist
MBBS, MCPS (Medicine), FCPS ( Medicine), FCPS (Endocrinology), SCE (Endocrinology & Diabetes, UK)
Gastroenterologist
MBBS, FCPS (Gastroenterology)
Gastroenterologist
MBBS, F.A.C.P (Medicine), Dip. (Medicine)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures